Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant

Recruiting N/A Interventional Study
Hematopoietic Stem Cell Transplantation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 120
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
222 (estimated)
Sponsor
National Cancer Institute (NCI) · NIH
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background: For adolescent and young adults (AYAs) with certain life-threatening illnesses, hematopoietic stem cell transplant (HSCT) provides the best chance for cure and survival. HSCT is a life-saving therapy, but this treatment also comes with significant risks. Given these risks, it is imperative that patients and their families have the opportunity to share their values, priorities, and goa…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: * AYA Participants: * Age \>= 18 to \<= 39 years. * Planned allogeneic HSCT at a participating site. * Participants must be English speaking. * Ability to understand and the willingness to sign a written informed consent document. * Caregiver Participants: * Age: \>…
Contacts

Brian W Pennarola, M.D.

(240) 760-7250

brian.pennarola@nih.gov

CONTACT